Family Based Contingency Management for Adolescent Alcohol Abuse
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT00595478 |
|
Recruitment Status :
Completed
First Posted : January 16, 2008
Results First Posted : March 29, 2018
Last Update Posted : March 29, 2018
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
The goal is to adapt the family-based CM treatment to target primary adolescent alcohol abuse and dependence.
Specific Aim 1 is to provide a preliminary demonstration of the efficacy of a family-based CM intervention to treat adolescent alcohol abuse and dependence. CM components include:
- an incentive program to enhance the adolescent's engagement in the treatment process and engender alcohol abstinence by providing positive reinforcement for documented abstinence via breathalyzers administered by parents regularly at home, self and parent report, and clinic-based urine drug testing; and
- a parent management training program to enhance and maintain the positive effects of the incentive program by teaching parents how to effectively use contingency management in the home environment to motivate their adolescent to achieve abstinence and improve their behavior in other domains.
A randomized trial will determine whether the CM intervention enhances outcomes when added to a standard individual cognitive behavioral therapy (CBT).
Specific Aim 2 is to determine whether and how treatment interventions modify parental and adolescent risk and protective factors using observational and laboratory measures (parenting practices, family functioning, risk taking, delay discounting, and child and parent psychopathology) and to determine whether these factors are associated with outcomes over time.
Specific Aim 3 is to test gene x environment (treatment) interactions in adolescent substance abuse. Findings will extend the scientific evidence for CM and support the ability of parents to implement CM at home. Findings that support the CM model's efficacy will make a significant contribution to research on the treatment of adolescent alcohol abuse, which has lagged behind research on adult substance abuse and on adolescent illicit drug use.
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Alcohol Abuse | Behavioral: Motivational Enhancement Therapy (MET)/CBT+CM Behavioral: Motivational Enhancement Therapy (MET)/CBT | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 75 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Treatment |
| Official Title: | Family Based Contingency Management for Adolescent Alcohol Abuse |
| Study Start Date : | August 2007 |
| Actual Primary Completion Date : | May 2014 |
| Actual Study Completion Date : | May 2014 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: 1
Motivational Enhancement Therapy (MET)/CBT+CM/BPT
|
Behavioral: Motivational Enhancement Therapy (MET)/CBT+CM
Behavioral Treatment |
|
Active Comparator: 2
Motivational Enhancement Therapy (MET)/CBT
|
Behavioral: Motivational Enhancement Therapy (MET)/CBT
Behavioral Treatment |
- Alcohol Abstinence [ Time Frame: Weekly up to 14 weeks ]Number of non-abstinent urinalysis (ETG-positive) samples during 14 weeks of treatment (considering missing samples as non-abstinent)
- Days of Alcohol Use During 36-week Follow-up Period [ Time Frame: Monthly up to 9 months (36 weeks) ]Percentage of days alcohol used during the 36-week follow-up period after treatment ended measured via timeline follow-back.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 12 Years to 18 Years (Child, Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- 12-18 years old (if 18, must attend high school and live at home)
- Report using alcohol during the previous 30 days
- Have a parent/guardian who can participate
- Meet DSM criteria for either Alcohol Abuse or Dependence
- Youth who meet DSM criteria for Alcohol Dependence may also meet criteria for Marijuana Abuse or Dependence and other Drug Abuse
- Youth who meet DSM criteria for Alcohol Abuse, may also meet criteria for Marijuana or other Drug Abuse
- Live within a 30-minute drive of the clinic
Exclusion Criteria:
- Meet DSM criteria for Drug Dependence (other than Marijuana Dependence)
- Meet DSM criteria for Alcohol Abuse with Marijuana Dependence. Use of other drugs will not be excluded
- Participants will also be excluded if they exhibit an active psychosis
- Have a severe medical or psychiatric illness that will limit participation
- Are pregnant or breast-feeding
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00595478
| United States, New Hampshire | |
| Geisel School of Medicine at Dartmouth | |
| Lebanon, New Hampshire, United States, 03766 | |
| Principal Investigator: | Catherine Stanger, Ph.D. | Dartmouth College |
| Responsible Party: | Catherine Stanger, Associate Professor, Dartmouth-Hitchcock Medical Center |
| ClinicalTrials.gov Identifier: | NCT00595478 |
| Other Study ID Numbers: |
85846 1R01AA016917-01 ( U.S. NIH Grant/Contract ) 1R01AA016917-02 ( U.S. NIH Grant/Contract ) 1R01AA016917-03 ( U.S. NIH Grant/Contract ) |
| First Posted: | January 16, 2008 Key Record Dates |
| Results First Posted: | March 29, 2018 |
| Last Update Posted: | March 29, 2018 |
| Last Verified: | March 2018 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
|
Alcoholism Alcohol-Related Disorders Substance-Related Disorders Chemically-Induced Disorders Mental Disorders |

